Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs

Drug-induced delayed hypersensitivity reactions (DHRs) is still a clinical and healthcare burden in every country. Increasing reports of DHRs have caught our attention to explore the genetic relationship, especially life-threatening severe cutaneous adverse drug reactions (SCARs), including acute ge...

Full description

Bibliographic Details
Main Authors: Chih-Hsuan Wung, Chuang-Wei Wang, Kuo-Chu Lai, Chun-Bing Chen, Wei-Ti Chen, Shuen-Iu Hung, Wen-Hung Chung, Taiwan Severe Cutaneous Adverse Reaction Consortium
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1183491/full
_version_ 1797839156261421056
author Chih-Hsuan Wung
Chuang-Wei Wang
Chuang-Wei Wang
Chuang-Wei Wang
Chuang-Wei Wang
Kuo-Chu Lai
Kuo-Chu Lai
Kuo-Chu Lai
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Wei-Ti Chen
Wei-Ti Chen
Wei-Ti Chen
Shuen-Iu Hung
Shuen-Iu Hung
Shuen-Iu Hung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Taiwan Severe Cutaneous Adverse Reaction Consortium
author_facet Chih-Hsuan Wung
Chuang-Wei Wang
Chuang-Wei Wang
Chuang-Wei Wang
Chuang-Wei Wang
Kuo-Chu Lai
Kuo-Chu Lai
Kuo-Chu Lai
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Wei-Ti Chen
Wei-Ti Chen
Wei-Ti Chen
Shuen-Iu Hung
Shuen-Iu Hung
Shuen-Iu Hung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Taiwan Severe Cutaneous Adverse Reaction Consortium
author_sort Chih-Hsuan Wung
collection DOAJ
description Drug-induced delayed hypersensitivity reactions (DHRs) is still a clinical and healthcare burden in every country. Increasing reports of DHRs have caught our attention to explore the genetic relationship, especially life-threatening severe cutaneous adverse drug reactions (SCARs), including acute generalized exanthematous pustulosis (AGEP), drug reactions with eosinophilia and systemic symptoms (DRESS), Stevens–Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). In recent years, many studies have investigated the immune mechanism and genetic markers of DHRs. Besides, several studies have stated the associations between antibiotics-as well as anti-osteoporotic drugs (AOD)-induced SCARs and specific human leukocyte antigens (HLA) alleles. Strong associations between drugs and HLA alleles such as co-trimoxazole-induced DRESS and HLA-B*13:01 (Odds ratio (OR) = 45), dapsone-DRESS and HLA-B*13:01 (OR = 122.1), vancomycin-DRESS and HLA-A*32:01 (OR = 403), clindamycin-DHRs and HLA-B*15:27 (OR = 55.6), and strontium ranelate (SR)-SJS/TEN and HLA-A*33:03 (OR = 25.97) are listed. We summarized the immune mechanism of SCARs, update the latest knowledge of pharmacogenomics of antibiotics- and AOD-induced SCARs, and indicate the potential clinical use of these genetic markers for SCARs prevention in this mini review article.
first_indexed 2024-04-09T15:53:37Z
format Article
id doaj.art-fa92ed091e0247a9bf442fb92c13bf47
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-09T15:53:37Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-fa92ed091e0247a9bf442fb92c13bf472023-04-26T05:10:41ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-04-011410.3389/fphar.2023.11834911183491Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugsChih-Hsuan Wung0Chuang-Wei Wang1Chuang-Wei Wang2Chuang-Wei Wang3Chuang-Wei Wang4Kuo-Chu Lai5Kuo-Chu Lai6Kuo-Chu Lai7Chun-Bing Chen8Chun-Bing Chen9Chun-Bing Chen10Chun-Bing Chen11Chun-Bing Chen12Chun-Bing Chen13Chun-Bing Chen14Chun-Bing Chen15Wei-Ti Chen16Wei-Ti Chen17Wei-Ti Chen18Shuen-Iu Hung19Shuen-Iu Hung20Shuen-Iu Hung21Wen-Hung Chung22Wen-Hung Chung23Wen-Hung Chung24Wen-Hung Chung25Wen-Hung Chung26Wen-Hung Chung27Wen-Hung Chung28Wen-Hung Chung29Wen-Hung Chung30Wen-Hung Chung31Wen-Hung Chung32Taiwan Severe Cutaneous Adverse Reaction ConsortiumChang Gung Memorial Hospital, Taoyuan, TaiwanDepartment of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei and Keelung, TaiwanCancer Vaccine and Immune Cell Therapy Core Laboratory, Department of Medical Research, Chang Gung Memorial Hospital, Taoyuan, TaiwanChang Gung Immunology Consortium, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, TaiwanDepartment of Dermatology, Xiamen Chang Gung Hospital, Xiamen, ChinaDepartment of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan, TaiwanGraduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, TaiwanDivision of Hematology and Oncology, Department of Internal Medicine, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation), New Taipei City, TaiwanDepartment of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei and Keelung, TaiwanCancer Vaccine and Immune Cell Therapy Core Laboratory, Department of Medical Research, Chang Gung Memorial Hospital, Taoyuan, TaiwanChang Gung Immunology Consortium, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, TaiwanDepartment of Dermatology, Xiamen Chang Gung Hospital, Xiamen, ChinaCollege of Medicine, Chang Gung University, Taoyuan, Taiwan0Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan1Immune-Oncology Center of Excellence, Chang Gung Memorial Hospital, Linkou, Taiwan2Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, TaiwanDepartment of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei and Keelung, TaiwanDepartment of Dermatology, Xiamen Chang Gung Hospital, Xiamen, ChinaCollege of Medicine, Chang Gung University, Taoyuan, TaiwanDepartment of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei and Keelung, TaiwanCancer Vaccine and Immune Cell Therapy Core Laboratory, Department of Medical Research, Chang Gung Memorial Hospital, Taoyuan, Taiwan3Institute of Pharmacology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanDepartment of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei and Keelung, TaiwanCancer Vaccine and Immune Cell Therapy Core Laboratory, Department of Medical Research, Chang Gung Memorial Hospital, Taoyuan, TaiwanChang Gung Immunology Consortium, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, TaiwanDepartment of Dermatology, Xiamen Chang Gung Hospital, Xiamen, ChinaCollege of Medicine, Chang Gung University, Taoyuan, Taiwan0Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan1Immune-Oncology Center of Excellence, Chang Gung Memorial Hospital, Linkou, Taiwan2Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan4Department of Dermatology, Beijing Tsinghua Chang Gung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China5Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China6Genomic Medicine Core Laboratory, Chang Gung Memorial Hospital, Linkou, TaiwanDrug-induced delayed hypersensitivity reactions (DHRs) is still a clinical and healthcare burden in every country. Increasing reports of DHRs have caught our attention to explore the genetic relationship, especially life-threatening severe cutaneous adverse drug reactions (SCARs), including acute generalized exanthematous pustulosis (AGEP), drug reactions with eosinophilia and systemic symptoms (DRESS), Stevens–Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). In recent years, many studies have investigated the immune mechanism and genetic markers of DHRs. Besides, several studies have stated the associations between antibiotics-as well as anti-osteoporotic drugs (AOD)-induced SCARs and specific human leukocyte antigens (HLA) alleles. Strong associations between drugs and HLA alleles such as co-trimoxazole-induced DRESS and HLA-B*13:01 (Odds ratio (OR) = 45), dapsone-DRESS and HLA-B*13:01 (OR = 122.1), vancomycin-DRESS and HLA-A*32:01 (OR = 403), clindamycin-DHRs and HLA-B*15:27 (OR = 55.6), and strontium ranelate (SR)-SJS/TEN and HLA-A*33:03 (OR = 25.97) are listed. We summarized the immune mechanism of SCARs, update the latest knowledge of pharmacogenomics of antibiotics- and AOD-induced SCARs, and indicate the potential clinical use of these genetic markers for SCARs prevention in this mini review article.https://www.frontiersin.org/articles/10.3389/fphar.2023.1183491/fulldelayed hypersensitivity reactionshuman leukocyte antigensStevens-Johnson syndrometoxic epidermal necrosisdrug reactions with eosinophilia and systemic symptoms
spellingShingle Chih-Hsuan Wung
Chuang-Wei Wang
Chuang-Wei Wang
Chuang-Wei Wang
Chuang-Wei Wang
Kuo-Chu Lai
Kuo-Chu Lai
Kuo-Chu Lai
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Chun-Bing Chen
Wei-Ti Chen
Wei-Ti Chen
Wei-Ti Chen
Shuen-Iu Hung
Shuen-Iu Hung
Shuen-Iu Hung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Wen-Hung Chung
Taiwan Severe Cutaneous Adverse Reaction Consortium
Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
Frontiers in Pharmacology
delayed hypersensitivity reactions
human leukocyte antigens
Stevens-Johnson syndrome
toxic epidermal necrosis
drug reactions with eosinophilia and systemic symptoms
title Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
title_full Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
title_fullStr Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
title_full_unstemmed Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
title_short Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs
title_sort current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti osteoporotic drugs
topic delayed hypersensitivity reactions
human leukocyte antigens
Stevens-Johnson syndrome
toxic epidermal necrosis
drug reactions with eosinophilia and systemic symptoms
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1183491/full
work_keys_str_mv AT chihhsuanwung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT chuangweiwang currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT chuangweiwang currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT chuangweiwang currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT chuangweiwang currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT kuochulai currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT kuochulai currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT kuochulai currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT chunbingchen currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT chunbingchen currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT chunbingchen currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT chunbingchen currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT chunbingchen currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT chunbingchen currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT chunbingchen currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT chunbingchen currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT weitichen currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT weitichen currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT weitichen currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT shueniuhung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT shueniuhung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT shueniuhung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT wenhungchung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT wenhungchung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT wenhungchung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT wenhungchung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT wenhungchung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT wenhungchung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT wenhungchung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT wenhungchung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT wenhungchung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT wenhungchung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT wenhungchung currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs
AT taiwanseverecutaneousadversereactionconsortium currentunderstandingofgeneticassociationswithdelayedhypersensitivityreactionsinducedbyantibioticsandantiosteoporoticdrugs